T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases
Authors:
- Eirik HøyeEHEirik Høye
- Vegar J DagenborgVDVegar J Dagenborg
- Annette TorgunrudATAnnette Torgunrud
- Christin Lund-AndersenCLChristin Lund-Andersen
- Åsmund A FretlandÅFÅsmund A Fretland
- Susanne LorenzSLSusanne Lorenz
- Bjørn EdwinBEBjørn Edwin
- Eivind HovigEHEivind Hovig
- Bastian FrommBFBastian Fromm
- Else M InderbergEIElse M Inderberg
- Victor GreiffVGVictor Greiff
- Anne H ReeARAnne H Ree
Open Access
- 28 December 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in GigaScience
- Vol. 12
Abstract
Background: Colorectal liver metastasis (CLM) is a leading cause of colorectal cancer mortality, and the response to immune checkpoint inhibition (ICI) in microsatellite-stable CRC has been disappointing. Administration of cytotoxic chemotherapy may cause increased density of tumor-infiltrating T cells, which has been associated with improved response to ICI. This study aimed to quantify and characterize T-cell infiltration in CLM using T-cell receptor (TCR) repertoire sequencing. Eighty-five resected CLMs from patients included in the Oslo CoMet study were subjected to TCR repertoire sequencing. Thirty-five and 15 patients had received neoadjuvant chemotherapy (NACT) within a short or long interval, respectively, prior to resection, while 35 patients had not been exposed to NACT. T-cell fractions were calculated, repertoire clonality was analyzed based on Hill evenness curves, and TCR sequence convergence was assessed using network analysis. Results: Increased T-cell fractions (10.6% vs. 6.3%) were detected in CLMs exposed to NACT within a short interval prior to resection, while modestly increased clonality was observed in NACT-exposed tumors independently of the timing of NACT administration and surgery. While private clones made up >90% of detected clones, network connectivity analysis revealed that public clones contributed the majority of TCR sequence convergence. Conclusions: TCR repertoire sequencing can be used to quantify T-cell infiltration and clonality in clinical samples. This study provides evidence to support chemotherapy-driven T-cell clonal expansion in CLM in a clinical context.Keywords
Funding Information
- South-Eastern Norway Regional Health Authority (2018014)
- Norwegian Cancer Society (215817)
This publication has 44 references indexed in Scilit:
- How behavioral economics can help to avoid ‘The last mile problem’ in whole genome sequencingGenome Medicine, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- CTLA4 Blockade Broadens the Peripheral T-Cell Receptor RepertoireClinical Cancer Research, 2014
- Network properties derived from deep sequencing of human B-cell receptor repertoires delineate B-cell populationsGenome Research, 2013
- Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopesCancer Immunology, Immunotherapy, 2011
- Sharing of T cell receptors in antigen-specific responses is driven by convergent recombinationProceedings of the National Academy of Sciences, 2006
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- WT1 is a tumor‐associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cellsInternational Journal of Cancer, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Diversity and Evenness: A Unifying Notation and Its ConsequencesEcology, 1973